Colitis with Hypereosinophilia following the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine: A Case Report with a Literature Review.
Intern Med
; 62(6): 865-869, 2023 Mar 15.
Article
in English
| MEDLINE | ID: covidwho-2257413
ABSTRACT
A 61-year-old man presented with a 7-day history of watery diarrhea and loss of appetite after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine. Laboratory studies showed significant eosinophilia and an elevated IgE level (white cell count, 18.4×109/L; eosinophil count, 9.5×109/L; and IgE level, 540 IU/L). Symptoms resolved 10 days after vaccination without any steroids or antiallergic medications, and the eosinophil count had also returned to within normal limits 2 months later. Several cases of eosinophilic disorders following receipt of any type of injectable COVID-19 vaccine have been reported, so the etiology should be examined.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Colitis
/
Eosinophilia
/
COVID-19 Vaccines
/
COVID-19
Type of study:
Case report
/
Etiology study
/
Observational study
/
Prognostic study
/
Reviews
Topics:
Vaccines
Limits:
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Intern Med
Journal subject:
Internal Medicine
Year:
2023
Document Type:
Article
Affiliation country:
Internalmedicine.0518-22
Similar
MEDLINE
...
LILACS
LIS